Both in Medical Labs
Sera Prognostics vs Fulgent Genetics
Over the past year SERA returned −45.9% and FLGT returned −8.2%; their daily moves had a correlation of 0.12.
SERA −45.9% FLGT −8.2%Growth of $1, one year, split-adjusted
| Metric | SERA | FLGT |
|---|---|---|
| Price | $2.03 | $21.52 |
| Market cap | $80.1M | $592.1M |
| Today | −0.98% | +3.96% |
| 1 month | +1.0% | −2.5% |
| 6 months | +2.0% | +45.4% |
| Year to date | −31.2% | −18.1% |
| 1 year | −45.7% | −7.7% |
| Revenue growth (YoY) | +76.5% | +4.4% |
| Gross margin | −66.7% | 30.1% |
| Net margin | −30463.3% | −34.6% |
| P/E (TTM) | — | — |
| Price / sales | 1,144.0× | 1.8× |
| Net cash | $46.4M | $256.6M |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 37.5% |
| Short % of float | 0.7% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).